These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35173515)

  • 1. Current Insights on the Impact of Gamma-Hydroxybutyrate (GHB) Abuse.
    Tay E; Lo WKW; Murnion B
    Subst Abuse Rehabil; 2022; 13():13-23. PubMed ID: 35173515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial.
    Lingford-Hughes A; Patel Y; Bowden-Jones O; Crawford MJ; Dargan PI; Gordon F; Parrott S; Weaver T; Wood DM
    Trials; 2016 Sep; 17(1):472. PubMed ID: 27677382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
    Busardò FP; Jones AW
    Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex.
    Busardò FP; Gottardi M; Tini A; Minutillo A; Sirignano A; Marinelli E; Zaami S
    Curr Drug Metab; 2018; 19(13):1080-1085. PubMed ID: 30251602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.
    Brennan R; Van Hout MC
    J Psychoactive Drugs; 2014; 46(3):243-51. PubMed ID: 25052883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.
    Palmer RB
    Toxicol Rev; 2004; 23(1):21-31. PubMed ID: 15298490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γ-Hydroxybutyrate (GHB) - Effects on Human Performance and Behavior.
    Couper FJ; Marinetti LJ
    Forensic Sci Rev; 2002 Feb; 14(1-2):101-21. PubMed ID: 26256488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-Hydroxybutyrate (GHB) Withdrawal in a Patient with Polysubstance Use.
    Bernstein A
    J Psychoactive Drugs; 2021; 53(4):299-301. PubMed ID: 33357048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons.
    Goodwin AK; Griffiths RR; Brown PR; Froestl W; Jakobs C; Gibson KM; Weerts EM
    Psychopharmacology (Berl); 2006 Nov; 189(1):71-82. PubMed ID: 17047936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
    Wood DM; Brailsford AD; Dargan PI
    Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
    McDaniel CH; Miotto KA
    J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
    Goodwin AK; Brown PR; Jansen EE; Jakobs C; Gibson KM; Weerts EM
    Psychopharmacology (Berl); 2009 Jun; 204(3):465-76. PubMed ID: 19198808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
    Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
    QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review.
    Ghio L; Cervetti A; Respino M; Belvederi Murri M; Amore M
    J Psychiatr Pract; 2014 Jul; 20(4):294-300. PubMed ID: 25036586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management.
    Marinelli E; Beck R; Malvasi A; Lo Faro AF; Zaami S
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):19-26. PubMed ID: 32597141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review.
    Siefried KJ; Freeman G; Roberts DM; Lindsey R; Rodgers C; Ezard N; Brett J
    Psychopharmacology (Berl); 2023 Jan; 240(1):127-135. PubMed ID: 36508055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inpatient management of GHB/GBL withdrawal.
    Delic M
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):354-356. PubMed ID: 31488752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans.
    Bosch OG; Seifritz E
    Brain Res Bull; 2016 Sep; 126(Pt 1):47-60. PubMed ID: 26855327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.